Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IRF7 anticorps (pSer477) (Alexa Fluor 488)

IRF7 Reactivité: Humain ICS Hôte: Souris Monoclonal K47-671 Alexa Fluor 488
N° du produit ABIN1177072
  • Antigène Voir toutes IRF7 Anticorps
    IRF7 (Interferon Regulatory Factor 7 (IRF7))
    Épitope
    • 17
    • 17
    • 15
    • 10
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer477
    Reactivité
    • 77
    • 55
    • 54
    • 17
    • 8
    • 3
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 69
    • 9
    Souris
    Clonalité
    • 58
    • 20
    Monoclonal
    Conjugué
    • 25
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp IRF7 est conjugé à/à la Alexa Fluor 488
    Application
    • 50
    • 18
    • 18
    • 14
    • 14
    • 13
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    Intracellular Staining (ICS)
    Marque
    BD Phosflow™
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    Phosphorylated Human IRF-7 Peptide
    Clone
    K47-671
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product IRF7 Anticorps primaire
  • Volume d'échantillon
    20 μL
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Aqueous buffered solution containing BSA and ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The antibody was conjugated to Alexa Fluor® 488 under optimum conditions, and unreacted Alexa Fluor® 488 was removed.
  • Paz, Sun, Nakhaei, Romieu-Mourez, Goubau, Julkunen, Lin, Hiscott: "Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway." dans: Cellular and molecular biology (Noisy-le-Grand, France), Vol. 52, Issue 1, pp. 17-28, (2006) (PubMed).

    Hoshino, Sugiyama, Matsumoto, Tanaka, Saito, Hemmi, Ohara, Akira, Kaisho: "IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9." dans: Nature, Vol. 440, Issue 7086, pp. 949-53, (2006) (PubMed).

    Sharma, tenOever, Grandvaux, Zhou, Lin, Hiscott: "Triggering the interferon antiviral response through an IKK-related pathway." dans: Science (New York, N.Y.), Vol. 300, Issue 5622, pp. 1148-51, (2003) (PubMed).

  • Antigène
    IRF7 (Interferon Regulatory Factor 7 (IRF7))
    Autre désignation
    IRF-7 (IRF7 Produits)
    Synonymes
    anticorps wu:fl24c03, anticorps zgc:66043, anticorps zgc:77947, anticorps IRF7, anticorps irf7, anticorps IRF-7H, anticorps IRF7A, anticorps IRF7B, anticorps IRF7C, anticorps IRF7H, anticorps interferon regulatory factor 7, anticorps irf7, anticorps IRF7, anticorps Irf7
    Sujet
    Interferon regulatory factor 7 (IRF-7) is a transcription factor that regulates anti-viral defenses by controlling the induction of type-I interferon (IFN) responses. IRF-7 expression is induced in lymphoid cells by virus infection, as well as by IFN, lipopolysaccharide, and TNF-a. IRF-7 responses are initiated by Toll-like receptors (TLR) or the cytoplasmic protein retinoic acid inducible gene I (RIG-I). Upon TLR activation, it forms cytoplasmic complexes with MyD88, an adaptor in the TLR signaling pathways. The TLR-dependent and RIG-I-dependent pathways activate kinases, such as IKK-e and TBK1, that phosphorylate IRF-7 and induce movement of IRF-7-containing complexes to the nucleus, where it preferentially activates IFN-a promoters. The K47-671 monoclonal antibody recognizes human IRF-7 phosphorylated at serines 477 and 479 (pS477/pS479). Our in-house testing is performed on a cell line that has been co-transfected with TBK1 and IRF-7. Phosphorylation of IRF-7 in the transfectants requires virus infection or over-expression of a signaling molecule of the RIG-I pathway, such as TBK1. Phosphorylation of endogenous IRF-7 in untransfected cells has not yet been detected. We confirmed that mAb K47-671 does not cross-react with TBK1 by Western blot analysis using the purified antibody.
    Pathways
    Signalisation TLR, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Autophagy
Vous êtes ici:
Support technique